These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7651489)

  • 1. Treatment of unresectable hepatocellular carcinoma.
    Vauthey JN; Marsh RW; Davis GL
    N Engl J Med; 1995 Sep; 333(13):877; author reply 878. PubMed ID: 7651489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
    Trinchet JC; Mathieu D; Beaugrand M
    Gastroenterol Clin Biol; 1995 Dec; 19(12):967-9. PubMed ID: 8729406
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of unresectable hepatocellular carcinoma.
    Bismuth H; Samuel D; Engerran L
    N Engl J Med; 1995 Sep; 333(13):878. PubMed ID: 7544440
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of unresectable hepatocellular carcinoma.
    Stuart K
    N Engl J Med; 1995 Sep; 333(13):877; author reply 878. PubMed ID: 7651488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemoembolization techniques for hepatocellular carcinoma in cirrhosis].
    Vetter D; Bronowicki JP; Doffoël M
    Ann Chir; 1998; 52(6):527-34. PubMed ID: 9752502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate.
    Koizumi J
    Cardiovasc Intervent Radiol; 2006; 29(5):928; author reply 929. PubMed ID: 16502170
    [No Abstract]   [Full Text] [Related]  

  • 7. The medical management of hepatocellular carcinoma (HCC) in Japan: a review with implications for HCC seen in the west.
    Ichida T; Van Thiel DH; Hassanein T
    Hepatogastroenterology; 1996; 43(12):1575-83. PubMed ID: 8975968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are prognostic factors of hepatocellular carcinoma known?].
    Zarski JP; Rolachon A
    Gastroenterol Clin Biol; 1993; 17(8-9):561-3. PubMed ID: 8253312
    [No Abstract]   [Full Text] [Related]  

  • 10. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non surgical treatments of hepatocellular carcinoma].
    Roche A
    Pathol Biol (Paris); 1992 Nov; 39(9):900-1. PubMed ID: 1311442
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of unresectable hepatocellular carcinoma.
    Rees CR
    N Engl J Med; 1995 Sep; 333(13):877-8. PubMed ID: 7651490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
    Chen M; Li J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.
    Bhattacharya S; Dusheiko GM
    Princess Takamatsu Symp; 1995; 25():253-64. PubMed ID: 8875631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma.
    Di Bisceglie AM
    Hepatology; 1991 Apr; 13(4):802-4. PubMed ID: 1849116
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indications and results of liver transplantation for hepatocellular carcinoma. Retrospective study in 17 patients].
    Girard-Morel V; Bresson-Hadni S; Ranfaing E; Heyd B; Raclot G; Franza A; Becker MC; Rohmer P; Gillet M; Mantion G
    Gastroenterol Clin Biol; 1993; 17(11):827-32. PubMed ID: 8143949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel intraarterial therapy for liver cancer using ethylbromopyruvate dissolved in an iodized oil.
    Choi YH; Chung JW; Son KR; So YH; Kim W; Yoon CJ; Yoon JH; Chung H; Kim HC; Jae HJ; Kim YI; Park JH
    Acad Radiol; 2011 Apr; 18(4):471-8. PubMed ID: 21237678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Comparison of lipiodol-assisted chemoembolization versus only conservative therapy in patients with nonresectable hepatocellular carcinomas-].
    Lorenz M; Waldeyer M; Müller HH
    Z Gastroenterol; 1996 Mar; 34(3):205-6. PubMed ID: 8650976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I; Hirashima N
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
    Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
    J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.